100 related articles for article (PubMed ID: 15205080)
1. Central venous line thrombosis in children and young adults with thalassemia major.
Finkelstein Y; Yaniv I; Berant M; Zilber R; Garty BZ; Epstein O; Lahav J; Tamary H
Pediatr Hematol Oncol; 2004; 21(5):375-81. PubMed ID: 15205080
[TBL] [Abstract][Full Text] [Related]
2. Significant association with location of central venous line placement and risk of venous thrombosis in children.
Male C; Julian JA; Massicotte P; Gent M; Mitchell L;
Thromb Haemost; 2005 Sep; 94(3):516-21. PubMed ID: 16268465
[TBL] [Abstract][Full Text] [Related]
3. DKA, CVL and DVT. Increased risk of deep venous thrombosis in children with diabetic ketoacidosis and femoral central venous lines.
Davis J; Surendran T; Thompson S; Corkey C
Ir Med J; 2007 Jan; 100(1):344. PubMed ID: 17380929
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of thrombotic children with malignancy.
Unal S; Varan A; Yalçin B; Büyükpamukçu M; Gürgey A
Ann Hematol; 2005 Jun; 84(6):395-9. PubMed ID: 15735962
[TBL] [Abstract][Full Text] [Related]
5. Intensification of chelating-therapy in patients with thalassemia major.
Laws HJ; Göbel U; Christaras A; Janssen G
Klin Padiatr; 2005; 217(3):120-5. PubMed ID: 15858702
[TBL] [Abstract][Full Text] [Related]
6. Long-term intravenous deferoxamine treatment for noncompliant transfusion-dependent beta-thalassemia patients.
Tamary H; Goshen J; Carmi D; Yaniv I; Kaplinsky C; Cohen IJ; Zaizov R
Isr J Med Sci; 1994 Aug; 30(8):658-64. PubMed ID: 8045754
[TBL] [Abstract][Full Text] [Related]
7. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies--a randomized, controlled study.
Ruud E; Holmstrøm H; De Lange C; Hogstad EM; Wesenberg F
Acta Paediatr; 2006 Sep; 95(9):1053-9. PubMed ID: 16938749
[TBL] [Abstract][Full Text] [Related]
8. Incidence and diagnosis of thrombosis in children with short-term central venous lines of the upper venous system.
Hanslik A; Thom K; Haumer M; Kitzmüller E; Albinni S; Wolfsberger M; Salzer-Muhar U; Male C
Pediatrics; 2008 Dec; 122(6):1284-91. PubMed ID: 19047247
[TBL] [Abstract][Full Text] [Related]
9. Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement.
McLean TW; Fisher CJ; Snively BM; Chauvenet AR
J Clin Oncol; 2005 May; 23(13):3024-9. PubMed ID: 15860859
[TBL] [Abstract][Full Text] [Related]
10. Sensory neural hearing loss in beta-thalassemia major patients treated with deferoxamine.
Shamsian BS; Aminasnafi A; Moghadassian H; Gachkar L; Arzanian MT; Alavi S; Esfehani H; Garallahi F; Amini R
Pediatr Hematol Oncol; 2008 Sep; 25(6):502-8. PubMed ID: 18728969
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of venous thromboembolism in children.
Male C; Kuhle S; Mitchell L
Semin Thromb Hemost; 2003 Aug; 29(4):377-90. PubMed ID: 14517750
[TBL] [Abstract][Full Text] [Related]
12. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
Shalitin S; Carmi D; Weintrob N; Phillip M; Miskin H; Kornreich L; Zilber R; Yaniv I; Tamary H
Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
[TBL] [Abstract][Full Text] [Related]
13. Study of intermittent intravenous deferrioxamine high-dose therapy in heavily iron-loaded children with beta-thalassemia major poorly compliant to subcutaneous injections.
Wali YA; Taqi A; Deghaidi A
Pediatr Hematol Oncol; 2004; 21(5):453-60. PubMed ID: 15205089
[TBL] [Abstract][Full Text] [Related]
14. A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia.
Pakbaz Z; Fischer R; Treadwell M; Yamashita R; Fung EB; Calvelli L; Quirolo K; Foote D; Harmatz P; Vichinsky EP
Ann N Y Acad Sci; 2005; 1054():486-91. PubMed ID: 16339703
[TBL] [Abstract][Full Text] [Related]
15. Thromboembolism in children with sarcoma.
Athale U; Cox S; Siciliano S; Chan AK
Pediatr Blood Cancer; 2007 Aug; 49(2):171-6. PubMed ID: 16991135
[TBL] [Abstract][Full Text] [Related]
16. Deep venous thrombosis in children and adolescents.
Levy ML; Granville RC; Hart D; Meltzer H
J Neurosurg; 2004 Aug; 101(1 Suppl):32-7. PubMed ID: 16206969
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for venous thromboembolism in children.
Gerotziafas GT
Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary thromboembolism in childhood: a single-center experience from Turkey.
Tavil B; Kuskonmaz B; Kiper N; Cetin M; Gumruk F; Gurgey A
Heart Lung; 2009; 38(1):56-65. PubMed ID: 19150531
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer.
Athale U; Siciliano S; Thabane L; Pai N; Cox S; Lathia A; Khan A; Armstrong A; Chan AK
Pediatr Blood Cancer; 2008 Dec; 51(6):792-7. PubMed ID: 18798556
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of inherited prothrombotic abnormalities and central venous catheter-related thrombosis in haematopoietic stem cell transplants recipients.
Abdelkefi A; Ben Romdhane N; Kriaa A; Chelli M; Torjman L; Ladeb S; Ben Othman T; Lakhal A; Guermazi S; Ben Hassen A; Ladeb F; Ben Abdeladhim A
Bone Marrow Transplant; 2005 Nov; 36(10):885-9. PubMed ID: 16151418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
